Segui
Tolga Acun
Tolga Acun
Moleküler Biyoloji ve Genetik Bölümü, Bülent Ecevit Üniversitesi
Email verificata su beun.edu.tr
Titolo
Citata da
Citata da
Anno
Killer toxin of Pichia anomala NCYC 432; purification, characterization and its exo-β-1, 3-glucanase activity
F İzgü, D Altınbay, T Acun
Enzyme and Microbial Technology 39 (4), 669-676, 2006
782006
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
T Acun, E Oztas, T Yagci, MC Yakicier
BMC cancer 11, 1-10, 2011
392011
HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer
T Acun, N Doberstein, JK Habermann, T Gemoll, C Thorns, E Oztas, ...
Omics: a journal of integrative biology 21 (5), 257-265, 2017
242017
PTPRD is Homozygously Deleted and Epigenetically Downregulated in Human Hepatocellular Carcinomas
T Acun, K Demir, E Oztas, D Arango, MC Yakicier
OMICS: A Journal of Integrative Biology 19 (4), 220-229, 2015
232015
Mdm2 Snp309 G allele displays high frequency and inverse correlation with somatic P53 mutations in hepatocellular carcinoma
T Acun, E Terzioğlu-Kara, O Konu, M Ozturk, MC Yakicier
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 684 (1 …, 2010
182010
Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer
T Acun, KM Senses
Breast Cancer 27 (3), 483-489, 2020
102020
High expression of DNAJA1 (HDJ2) predicts unfavorable survival outcomes in breast cancer
FC Ileri, T Acun
Biomarkers in medicine 15 (12), 941-950, 2021
62021
Role of FLT3 in the proliferation and aggressiveness of hepatocellular carcinoma
MM Aydin, NS Bayin, T Acun, MC Yakicier, KC Akcali
Turkish Journal of Medical Sciences 46 (2), 572-581, 2016
52016
Muscle hemangiomatosis presenting as a severe feature in a patient with the pten mutation: expanding the phenotype of vascular malformations in bannayan-riley-ruvalcaba syndrome
Y Soysal, T Acun, CM Lourenço, W Marques, MC Yakıcıer
Balkan Journal of Medical Genetics 15 (1), 45-50, 2012
32012
Isolation characterization of the K4 type yeast killer toxin
T Acun
Middle East Technical University, 2003
22003
DNAJC9 expression in basal-like and luminal A breast cancer subtypes predicts worse survival
O Incekara, T Acun
Molecular Biology Reports 50 (9), 7275-7282, 2023
12023
DNAJB11 (ERDJ3) Expression is a Novel Risk Factor for Breast Cancer Survival
A Tolga
J. Int. Transl. Med 8, 13-18, 2020
12020
Identification of ALX3 Gene Promoter Hypermethylation as a Potential Biomarker for Lung Cancer
EB Kartaloglu, M Oztepe, O Akgun, T Acun, F Ari, E Uz-Yildirim
Anticancer Research 43 (7), 3029-3036, 2023
2023
High expression correlates with poor survival outcomes in breast cancer
T Acun, O Incekara
Revista Romana de Medicina de Laborator 30 (4), 369-378, 2022
2022
DNAJC10 (ERDJ5) is a novel biomarker candidate in breast cancer.
T Acun, KM Senses
Erciyes Medical Journal 41 (S1), 17-19, 2019
2019
518 Genetic and Epigenetic Alterations of PTPRD in Hepatocellular Carcinoma
T Acun, K Demir, E Oztas, MC Yakicier
european journal of cancer, S123, 2012
2012
Genetic and epigenetic evaluation of the candidate genes in human hepatocellular carcinomas
T Acun
PQDT-Global, 2010
2010
A BRANCHED DNA-BASED TECHNIQUE FOR DETECTION OF BCR-ABL GENE PRODUCTS
M Yakicier, T Acun, S Dizlek, A Timuragaoglu
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL 94, 17-17, 2009
2009
Genetic analysis of hepatocellular carcinoma candidate tumour suppressor genes and oncogenes
T Acun, C Yakicier
FEBS JOURNAL 273, 369-369, 2006
2006
DNAJC25 as a tumor suppressor candidate gene in breast cancer Meme Kanserinde tümör baskılayıcı gen adayı olarak DNAJC25
T Acun
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20